Literature DB >> 20639089

STAT3 implicated in the development of colon cancer: a step closer for targeted therapy?

George K K Lau1, Dewei Ye.   

Abstract

Entities:  

Year:  2010        PMID： 20639089     DOI： 10.1053/j.gastro.2010.05.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.

Authors:  Teppei Morikawa; Yoshifumi Baba; Mai Yamauchi; Aya Kuchiba; Katsuhiko Nosho; Kaori Shima; Noriko Tanaka; Curtis Huttenhower; David A Frank; Charles S Fuchs; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2011-02-10       Impact factor: 12.531

2.  Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro.

Authors:  Weidong Li; Shakir M Saud; Matthew R Young; Nancy H Colburn; Baojin Hua
Journal:  Mol Cell Biochem       Date:  2015-04-26       Impact factor: 3.396

3.  Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.

Authors:  Yushan Yang; Lulu Ma; Yiming Xu; Yun Liu; Wenya Li; Jianchun Cai; Yiyao Zhang
Journal:  Cell Death Dis       Date:  2020-06-24       Impact factor: 8.469

4.  SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.

Authors:  Yan Huang; Jie Wang; Fuao Cao; Hailong Jiang; An Li; Jianzhong Li; Lei Qiu; Hao Shen; Wenjun Chang; Chuanxiang Zhou; Yamin Pan; Yiming Lu
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

5.  Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.

Authors:  Rizwan Ahmad; Punita Dhawan; Amar B Singh
Journal:  Biochem Pharmacol (Los Angel)       Date:  2016-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.